Literature DB >> 17157419

Exposure to heat and freezing in the vaccine cold chain in Thailand.

Sirirat Techathawat1, Porpit Varinsathien, Aimorn Rasdjarmrearnsook, Piyanit Tharmaphornpilas.   

Abstract

This study investigated exposure to heat and freezing of vaccines used in Thailand's National Immunization Program. Cold chain temperatures on 48 randomly selected shipment routes nationwide were monitored. Measles and hepatitis B vaccines were despatched with recording devices and subsequently tested. The study found that extremes of cold appear to be the more significant problem. Heat exposure was relatively brief and not at very high temperatures, so vaccine deterioration was unlikely, as was confirmed by measles vaccine testing. Exposure to temperatures below -0.5 degrees C was widespread, which would be expected to damage hepatitis B vaccine, but shake tests did not detect damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157419     DOI: 10.1016/j.vaccine.2006.09.092

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  A freeze-stable formulation for DTwP and DTaP vaccines.

Authors:  Honggang Xue; Bangling Yang; Debra D Kristensen; Dexiang Chen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Evaluation of an outside-the-cold-chain vaccine delivery strategy in remote regions of western China.

Authors:  Qian Ren; Hongyan Xiong; Yafei Li; Rufu Xu; Caizhong Zhu
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

3.  Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.

Authors:  Osman David Mansoor; Debra Kristensen; Andrew Meek; Simona Zipursky; Olga Popova; Olga Popovaa; InderJit Sharma; Gisele Miranda; Jules Millogo; Heidi Lasher
Journal:  Bull World Health Organ       Date:  2012-11-05       Impact factor: 9.408

4.  Validation of the shake test for detecting freeze damage to adsorbed vaccines.

Authors:  Umit Kartoglu; Nejat Kenan Ozgüler; Lara J Wolfson; Wiesław Kurzatkowski
Journal:  Bull World Health Organ       Date:  2010-02-09       Impact factor: 9.408

5.  Comparative cost models of a liquid nitrogen vapor phase (LNVP) cold chain-distributed cryopreserved malaria vaccine vs. a conventional vaccine.

Authors:  Cristina Reyes Garcia; Fatuma Manzi; Fabrizio Tediosi; Stephen L Hoffman; Eric R James
Journal:  Vaccine       Date:  2012-11-10       Impact factor: 3.641

6.  The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.

Authors:  Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-01-04       Impact factor: 3.452

7.  Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.

Authors:  Pat Lennon; Brian Atuhaire; Shahrzad Yavari; Vidya Sampath; Mercy Mvundura; Nithya Ramanathan; Joanie Robertson
Journal:  Vaccine       Date:  2017-04-19       Impact factor: 3.641

Review 8.  Tools and approaches to ensure quality of vaccines throughout the cold chain.

Authors:  Umit Kartoglu; Julie Milstien
Journal:  Expert Rev Vaccines       Date:  2014-05-28       Impact factor: 5.217

9.  Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.

Authors:  Bishwa B Adhikari; James L Goodson; Susan Y Chu; Paul A Rota; Martin I Meltzer
Journal:  Drugs R D       Date:  2016-12

10.  [Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014].

Authors:  Dadja Essoya Landoh; Anna-Léa Kahn; Anani Lacle; Kodjovi Adjeoda; Bayaki Saka; Issifou Yaya; Danladi Ibrahim Nassoury; Assima Kalao; Makawa-Sy Makawa; Nsiari-Mueyi Joseph Biey; Andre Bita; Yaovi Temfa Toke; Petit Dörte; Lucile Imboua; Olivier Ronveaux
Journal:  Pan Afr Med J       Date:  2017-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.